Literature DB >> 19357323

Lipid changes during the menopause transition in relation to age and weight: the Study of Women's Health Across the Nation.

Carol A Derby1, Sybil L Crawford, Richard C Pasternak, Maryfran Sowers, Barbara Sternfeld, Karen A Matthews.   

Abstract

Few studies have prospectively examined lipid changes across the menopause transition or in relation to menopausal changes in endogenous hormones. The relative independent contributions of menopause and age to lipid changes are unclear. Lipid changes were examined in relation to changes in menopausal status and in levels of estradiol and follicle-stimulating hormone in 2,659 women followed in the Study of Women's Health Across the Nation (1995-2004). Baseline age was 42-52 years, and all were initially pre- or perimenopausal. Women were followed annually for up to 7 years (average, 3.9 years). Lipid changes occurred primarily during the later phases of menopause, with menopause-related changes similar in magnitude to changes attributable to aging. Total cholesterol, low density lipoprotein cholesterol, triglycerides, and lipoprotein(a) peaked during late peri- and early postmenopause, while changes in the early stages of menopause were minimal. The relative odds of low density lipoprotein cholesterol (> or =130 mg/dL) for early postmenopausal, compared with premenopausal, women were 2.1 (95% confidence interval: 1.5, 2.9). High density lipoprotein cholesterol also peaked in late peri- and early postmenopause. Results for estradiol and follicle-stimulating hormone confirmed the results based on status defined by bleeding patterns. Increases in lipids were smallest in women who were heaviest at baseline.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19357323      PMCID: PMC2727246          DOI: 10.1093/aje/kwp043

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  38 in total

1.  A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol.

Authors:  G R Warnick; J J Albers
Journal:  J Lipid Res       Date:  1978-01       Impact factor: 5.922

2.  Using longitudinal data to define the perimenopause by menstrual cycle characteristics.

Authors:  E C Dudley; J L Hopper; J Taffe; J R Guthrie; H G Burger; L Dennerstein
Journal:  Climacteric       Date:  1998-03       Impact factor: 3.005

3.  Lipoproteins and BMI: a comparison between women during transition to menopause and regularly menstruating healthy women.

Authors:  Gerd Hall; Aila Collins; György Csemiczky; Britt-Marie Landgren
Journal:  Maturitas       Date:  2002-03-25       Impact factor: 4.342

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  The epidemiology of plasma high-density lipoprotein cholesterol levels. The Lipid Research Clinics Program Prevalence Study. Summary.

Authors:  G Heiss; N J Johnson; S Reiland; C E Davis; H A Tyroler
Journal:  Circulation       Date:  1980-11       Impact factor: 29.690

6.  Physical activity and changes in weight and waist circumference in midlife women: findings from the Study of Women's Health Across the Nation.

Authors:  Barbara Sternfeld; Hua Wang; Charles P Quesenberry; Barbara Abrams; Susan A Everson-Rose; Gail A Greendale; Karen A Matthews; Javier I Torrens; MaryFran Sowers
Journal:  Am J Epidemiol       Date:  2004-11-01       Impact factor: 4.897

7.  Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN.

Authors:  M R Sowers; G A Greendale; I Bondarenko; J S Finkelstein; J A Cauley; R M Neer; B Ettinger
Journal:  Osteoporos Int       Date:  2003-04-11       Impact factor: 4.507

8.  Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age.

Authors:  John F Randolph; MaryFran Sowers; Irina V Bondarenko; Siobán D Harlow; Judith L Luborsky; Roderick J Little
Journal:  J Clin Endocrinol Metab       Date:  2004-04       Impact factor: 5.958

9.  Menopause and risk of cardiovascular disease: the Framingham study.

Authors:  W B Kannel; M C Hjortland; P M McNamara; T Gordon
Journal:  Ann Intern Med       Date:  1976-10       Impact factor: 25.391

10.  Association of lipoprotein(a), insulin resistance, and reproductive hormones in a multiethnic cohort of pre- and perimenopausal women (The SWAN Study).

Authors:  MaryFran Sowers; Sybil L Crawford; Jane A Cauley; Evan Stein
Journal:  Am J Cardiol       Date:  2003-09-01       Impact factor: 2.778

View more
  84 in total

1.  The effect of diet and cardiovascular risk on ovarian aging in cynomolgus monkeys (Macaca fascicularis).

Authors:  Susan E Appt; Haiying Chen; Amanda K Goode; Patricia B Hoyer; Thomas B Clarkson; Michael R Adams; Mark E Wilson; Adrian A Franke; Jay R Kaplan
Journal:  Menopause       Date:  2010-07       Impact factor: 2.953

2.  Cholesterol Efflux Capacity and Subclasses of HDL Particles in Healthy Women Transitioning Through Menopause.

Authors:  Samar R El Khoudary; Patrick M Hutchins; Karen A Matthews; Maria M Brooks; Trevor J Orchard; Graziella E Ronsein; Jay W Heinecke
Journal:  J Clin Endocrinol Metab       Date:  2016-07-11       Impact factor: 5.958

Review 3.  Predictors of cardiovascular risk in women.

Authors:  Tamer Sallam; Karol E Watson
Journal:  Womens Health (Lond)       Date:  2013-09

4.  A moderate intake of phytosterols from habitual diet affects cholesterol metabolism.

Authors:  T Sanclemente; I Marques-Lopes; M Fajó-Pascual; M Cofán; E Jarauta; E Ros; J Puzo; A L García-Otín
Journal:  J Physiol Biochem       Date:  2009-12       Impact factor: 4.158

5.  Association between gaseous air pollutants and inflammatory, hemostatic and lipid markers in a cohort of midlife women.

Authors:  Xiangmei May Wu; Rupa Basu; Brian Malig; Rachel Broadwin; Keita Ebisu; Ellen B Gold; Lihong Qi; Carol Derby; Rochelle S Green
Journal:  Environ Int       Date:  2017-07-26       Impact factor: 9.621

6.  Consistent ovulation may not be enough to make women healthy when approaching menopause: an update from the Study of Women's Health Across the Nation.

Authors:  Amanda A Allshouse; Alex Polotsky; Sybil Crawford; Hsiang-Yu Chen; Samar R El Khoudary; Nanette Santoro
Journal:  Menopause       Date:  2015-03       Impact factor: 2.953

7.  Serum lipids, lipoproteins, and risk of breast cancer: a nested case-control study using multiple time points.

Authors:  Lisa J Martin; Olga Melnichouk; Ella Huszti; Philip W Connelly; Carolyn V Greenberg; Salomon Minkin; Norman F Boyd
Journal:  J Natl Cancer Inst       Date:  2015-03-28       Impact factor: 13.506

8.  Vasomotor symptoms and lipid profiles in women transitioning through menopause.

Authors:  Rebecca C Thurston; Samar R El Khoudary; Kim Sutton-Tyrrell; Carolyn J Crandall; Ellen B Gold; Barbara Sternfeld; Hadine Joffe; Faith Selzer; Karen A Matthews
Journal:  Obstet Gynecol       Date:  2012-04       Impact factor: 7.661

9.  Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition?

Authors:  Karen A Matthews; Sybil L Crawford; Claudia U Chae; Susan A Everson-Rose; Mary Fran Sowers; Barbara Sternfeld; Kim Sutton-Tyrrell
Journal:  J Am Coll Cardiol       Date:  2009-12-15       Impact factor: 24.094

10.  Does accelerated reproductive aging underlie premenopausal risk for cardiovascular disease?

Authors:  Maria E Bleil; Steven E Gregorich; Daniel McConnell; Mitchell P Rosen; Marcelle I Cedars
Journal:  Menopause       Date:  2013-11       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.